Patents by Inventor Jeffrey Lester Brown

Jeffrey Lester Brown has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160251421
    Abstract: The invention relates to agents which possess anti-antigenic activity and are accordingly useful in methods of treatment of disease states associated with angiogenesis in the animal or human body. More specifically the invention concerns a combination of an antagonist of the biological activity of Angiopoietin-2 and an antagonist of the biological activity of VEGF-A, and/or KDR, and/or Flt1, and uses of such antagonists.
    Type: Application
    Filed: February 29, 2016
    Publication date: September 1, 2016
    Inventors: Jeffrey Lester Brown, Stephen Charles Emery, David Charles Blakey
  • Publication number: 20140023654
    Abstract: The invention relates to agents which possess anti-angiogenic activity and are accordingly useful in methods of treatment of disease states associated with angiogenesis in the animal or human body. More specifically the invention concerns a combination of an antagonist of the biological activity of Angiopoietin-2 and an antagonist of the biological activity of VEGF-A, and/or KDR, and/or Flt1, and uses of such antagonists.
    Type: Application
    Filed: July 29, 2013
    Publication date: January 23, 2014
    Applicant: Medimmune Limited
    Inventors: Jeffrey Lester BROWN, Stephen Charles Emery, David Charles Blakey
  • Publication number: 20120288497
    Abstract: The invention relates to agents which possess anti-angiogenic activity and are accordingly useful in methods of treatment of disease states associated with angiogenesis in the animal or human body. More specifically the invention concerns a combination of an antagonist of the biological activity of Angiopoietin-2 and an antagonist of the biological activity of VEGF-A, and/or KDR, and/or Flt1, and uses of such antagonists.
    Type: Application
    Filed: May 16, 2012
    Publication date: November 15, 2012
    Applicant: MedImmune Limited
    Inventors: DAVID CHARLES BLAKEY, JEFFREY LESTER BROWN, STEPHEN CHARLES EMERY
  • Publication number: 20110097321
    Abstract: The invention relates to agents which possess anti-angiogenic activity and are accordingly useful in methods of treatment of disease states associated with angiogenesis in the animal or human body. More specifically the invention concerns a combination of an antagonist of the biological activity of Angiopoietin-2 and an antagonist of the biological activity of VEGF-A, and/or KDR, and/or Flt1, and uses of such antagonists.
    Type: Application
    Filed: September 24, 2010
    Publication date: April 28, 2011
    Applicant: ASTRAZENECA AB
    Inventors: David Charles BLAKEY, Jeffrey Lester BROWN, Stephen Charles EMERY
  • Publication number: 20090123474
    Abstract: The invention relates to agents which possess anti-angiogenic activity and are accordingly useful in methods of treatment of disease states associated with angiogenesis in the animal or human body. More specifically the invention concerns a combination of an antagonist of the biological activity of Angiopoietin-2 and an antagonist of the biological activity of VEGF-A, and/or KDR, and/or Flt1, and uses of such antagonists.
    Type: Application
    Filed: December 12, 2006
    Publication date: May 14, 2009
    Applicant: ASTRAZENECA AB
    Inventors: David Charles Blakey, Jeffrey Lester Brown, Stephen Charles Emery